Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Prostatic Diseases × enzalutamide × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 83 Breast Neoplasms 10 Neoplasm Metastasis 7 Neoplasms 5 Prostatic Neoplasms, Castration-Resistant 4 Prostate Cancer Metastatic 4 Metastatic Castration-Resistant Prostate Cancer 4 Metastatic Castration-resistant Prostate Cancer 3 Castration-resistant Prostate Cancer 3 Triple Negative Breast Neoplasms 2 Castration Resistant Metastatic Prostate Cancer 2 Adenocarcinoma of the Prostate 2 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Salivary Cancer 1 Recurrent Endometrial Endometrioid Adenocarcinoma 1 Prostatic Diseases 1 Prostate Carcinoma Metastatic to the Bone 1 Prostate Adenocarcinoma 1 Primary Breast Cancer ER+ve 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Neoplasms 1 Non-metastatic, Hormone naïve Prostate Cancer 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoadjuvant Therapy 1 NSCLC Harboring NRG1 Fusion 1 Metastatic Progressive Castration-resistant Prostate Cancer 1 Metastatic Hormone-sensitive Prostate Cancer 1 Metastatic Castration-Resistant Prostate Cancer (mCRPC) 1

Interventions

padeliporfin 2 talazoparib 1 sipuleucel-T 1 luprolide acetate gel depot 1 ixabepilone 1 enzalutamide 1 Therapeutics 1 Pluvicto 1 Paclitaxel 1 Nivolumab 1 Leuprolide 1 Ipilimumab 1 Imatinib Mesylate 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06582628 2024-12-02

TEAM PC

Fundacion Oncosur

Phase 2 Recruiting

Prostatic Diseases, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡